Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 37 results.
User Information
Export Records
  1. 1.   Aging and CNS Myeloid Cell Depletion Attenuate Breast Cancer Brain Metastasis
  2. Wu, Alex Man Lai; Gossa, Selamawit; Samala, Ramakrishna; Chung, Monika A.; Gril, Brunilde; Yang, Howard H.; Thorsheim, Helen R.; Tran, Andy D.; Wei, Debbie; Taner, Esra; Isanogle,Kristine; Yang, Yuan; Dolan, Emma L.; Robinson,Christina; Difilippantonio,Simone; Lee, Maxwell P.; Khan, Imran; Smith, Quentin R.; McGavern, Dorian B.; Wakefield, Lalage M.; Steeg, Patricia S.
  3. CLINICAL CANCER RESEARCH. 2021, Aug 1; 27(15): 4422-4434.
  1. 2.   Tumor-associated macrophage, angiogenesis and lymphangiogenesis markers predict prognosis of non-small cell lung cancer patients
  2. Hwang, Ilseon; Kim, Jeong Won; Ylaya, Kris; Chung, Eun Joo; Kitano, Haruhisa; Perry,Candice; Hanaoka, Jun; Fukuoka, Junya; Chung, Joon-Yong; Hewitt, Stephen M
  3. Journal of translational medicine. 2020, Nov 23; 18(1): 443.
  1. 3.   GATA3 and APOBEC3B are prognostic markers in adrenocortical carcinoma and APOBEC3B is directly transcriptionally regulated by GATA3
  2. Gara, Sudheer Kumar; Tyagi, Monica Varun; Patel, Dhaval Thakkur; Gaskins, Kelli; Lack,Justin; Liu, Yi; Kebebew, Electron
  3. Oncotarget. 2020, Sep 08; 11(36): 3354-3370.
  1. 4.   Analysis of Ugandan cervical carcinomas identifies human papillomavirus clade-specific epigenome and transcriptome landscapes
  2. Gagliardi, Alessia; Porter, Vanessa L; Zong, Zusheng; Bowlby, Reanne; Titmuss, Emma; Namirembe, Constance; Griner, Nicholas B; Petrello, Hilary; Bowen, Jay; Chan, Simon K; Culibrk, Luka; Darragh, Teresa M; Stoler, Mark H; Wright, Thomas C; Gesuwan, Patee; Dyer,Maureen; Ma, Yussanne; Mungall, Karen L; Jones, Steven J M; Nakisige, Carolyn; Novik, Karen; Orem, Jackson; Origa, Martin; Gastier-Foster, Julie M; Yarchoan, Robert; Casper, Corey; Mills, Gordon B; Rader, Janet S; Ojesina, Akinyemi I; Gerhard, Daniela S; Mungall, Andrew J; Marra, Marco A
  3. Nature genetics. 2020, Aug; 52(8): 800-810.
  1. 5.   Dysregulated microRNAs in Hepatitis B Virus-Related Hepatocellular Carcinoma: Potential as Biomarkers and Therapeutic Targets
  2. Xu, Jinghang; An,Ping; Winkler,Cheryl; Yu, Yanyan
  3. Frontiers in oncology. 2020, JUL 28; 10
  1. 6.   Integrated analysis of genome-wide miRNAs and targeted gene expression in esophageal squamous cell carcinoma (ESCC) and relation to prognosis
  2. Yang, Howard; Su, Hua; Hu, Nan; Wang, Chaoyu; Wang, Lemin; Giffen, Carol; Goldstein, Alisa M; Lee, Maxwell P; Taylor, Philip R
  3. BMC cancer. 2020, May 06; 20(1): 388.
  1. 7.   Integration of proteomics with CT-based qualitative and radiomic features in high-grade serous ovarian cancer patients: an exploratory analysis
  2. Beer, Lucian; Sahin, Hilal; Bateman, Nicholas W; Blazic, Ivana; Vargas, Hebert Alberto; Veeraraghavan, Harini; Kirby,Justin; Fevrier-Sullivan,Brenda; Freymann,John; Jaffe, C Carl; Brenton, James; Miccó, Maura; Nougaret, Stephanie; Darcy, Kathleen M; Maxwell, G Larry; Conrads, Thomas P; Huang, Erich; Sala, Evis
  3. European radiology. 2020, Apr 06; pii: 10.1007/s00330-020-06755-3.
  1. 8.   Agreement in Histological Assessment of Mitotic Activity Between Microscopy and Digital Whole Slide Images Informs Conversion for Clinical Diagnosis
  2. Wei,Bih; Halsey, Charles H; Hoover, Shelley B; Puri, Munish; Yang, Howard H; Gallas, Brandon D; Lee, Maxwell P; Chen, Weijie; Durham, Amy C; Dwyer, Jennifer E; Sánchez, Melissa D; Traslavina, Ryan P; Frank, Chad; Bradley, Charles; McGill, Lawrence D; Esplin, D Glen; Schaffer, Paula A; Cramer, Sarah D; Lyle, L Tiffany; Beck, Jessica; Buza, Elizabeth; Gong, Qi; Hewitt, Stephen M; Simpson, R Mark
  3. Academic pathology. 2019, JUL 11; 6
  1. 9.   Integrated analysis of competing endogenous RNA network revealing potential prognostic biomarkers of hepatocellular carcinoma
  2. Liao, Xiwen; Wang, Xiangkun; Huang, Ketuan; Han, Chuangye; Deng, Jianlong; Yu, Tingdong; Yang, Chengkun; Huang, Rui; Liu, Xiaoguang; Yu, Long; Zhu, Guangzhi; Su, Hao; Qin, Wei; Zeng, Xianmin; Han, Bowen; Han, Quanfa; Liu, Zhengqian; Zhou, Xin; Gong, Yizhen; Liu, Zhengtao; Huang, Jianly; Winkler,Cheryl; O'Brien, Stephen J.; Ye, Xinping; Peng, Tao
  3. JOURNAL OF CANCER. 2019, Jun 2; 10(14): 3267-3283.
  1. 10.   A Tumor-Selective Monoclonal Antibody from Immunization with a Tumor-Associated Mucin Glycopeptide
  2. Trabbic,Kevin; Whalen, Kaitlyn; Abarca-Heideman, Karin; Xia, Li; Temme,Sebastian; Edmondson,Elijah; Gildersleeve,Jeffrey; Barchi,Joe
  3. Scientific reports. 2019, Apr 5; 9(1):
  1. 11.   Automated Computational Detection, Quantitation, and Mapping of Mitosis in Whole-Slide Images for Clinically Actionable Surgical Pathology Decision Support
  2. Puri, Munish; Hoover, Shelley B; Hewitt, Stephen M; Wei,Bih; Adissu, Hibret Amare; Halsey, Charles H C; Beck, Jessica; Bradley, Charles; Cramer, Sarah D; Durham, Amy C; Esplin, D Glen; Frank, Chad; Lyle, L Tiffany; McGill, Lawrence D; Sánchez, Melissa D; Schaffer, Paula A; Traslavina, Ryan P; Buza, Elizabeth; Yang, Howard H; Lee, Maxwell P; Dwyer, Jennifer E; Simpson, R Mark
  3. Journal of pathology informatics. 2019, Feb; 10: 4.
  1. 12.   Cripto-1 acts as a functional marker of cancer stem-like cells and predicts prognosis of the patients in esophageal squamous cell carcinoma
  2. Liu, Qiang; Cui, Xiang; Yu, Xi; Bian, Bai-Shi-Jiao; Qian, Feng; Hu, Xu-Gang; Ji, Cheng-Dong; Yang, Lang; Ren, Yong; Cui, Wei; Zhang, Xia; Zhang, Peng; Wang, Jiming; Cui, You-Hong; Bian, Xiu-Wu
  3. MOLECULAR CANCER. 2017, Apr 21; 16(1): 81.
  1. 13.   Cancer stem cells: a systems biology view of their role in prognosis and therapy
  2. Mertins, S. D.
  3. Anti-Cancer Drugs. 2014, Apr; 25(4): 353-67.
  1. 14.   Faithful Markers of Circulating Cancer Stem Cells: Is CD133 Sufficient for Validation in Clinics?
  2. Crea, F.; Fornaro, L.; Masi, G.; Falcone, A.; Danesi, R.; Farrar, W.
  3. Journal of Clinical Oncology. 2011, Sep; 29(25): 3487-3488.
  1. 15.   Integrated miRNA and mRNA expression profiling of mouse mammary tumor models identifies miRNA signatures associated with mammary tumor lineage
  2. Zhu, M.; Yi, M.; Kim, C. H.; Deng, C. X.; Li, Y.; Medina, D.; Stephens, R. M.; Green, J. E.
  3. Genome Biology. 2011, Aug 16; 12(8): 16.
  1. 16.   Multihistology, Target-Driven Pilot Trial of Oral Topotecan as an Inhibitor of Hypoxia-Inducible Factor-1 alpha in Advanced Solid Tumors
  2. Kummar, S.; Raffeld, M.; Juwara, L.; Horneffer, Y.; Strassberger, A.; Allen, D.; Steinberg, S. M.; Rapisarda, A.; Spencer, S. D.; Figg, W. D.; Chen, X. H.; Turkbey, I. B.; Choyke, P.; Murgo, A. J.; Doroshow, J. H.; Melillo, G.
  3. Clinical Cancer Research. 2011, Aug; 17(15): 5123-5131.
  1. 17.   Coactivation of AKT and beta-Catenin in Mice Rapidly Induces Formation of Lipogenic Liver Tumors
  2. Stauffer, J. K.; Scarzello, A. J.; Andersen, J. B.; De Kluyver, R. L.; Back, T. C.; Weiss, J. M.; Thorgeirsson, S. S.; Wiltrout, R. H.
  3. Cancer Research. 2011, Apr; 71(7): 2718-2727.
  1. 18.   Tumor suppressor FLCN inhibits tumorigenesis of a FLCN-null renal cancer cell line and regulates expression of key molecules in TGF-beta signaling
  2. Hong, S. B.; Oh, H.; Valera, V. A.; Stull, J.; Ngo, D. T.; Baba, M.; Merino, M. J.; Linehan, W. M.; Schmidt, L. S.
  3. Molecular Cancer. 2010, Jun; 9: 13.
  1. 19.   mRNA and microRNA Expression Profiles of the NCI-60 Integrated with Drug Activities
  2. Liu, H. F.; D'Andrade, P.; Fulmer-Smentek, S.; Lorenzi, P.; Kohn, K. W.; Weinstein, J. N.; Pommier, Y.; Reinhold, W. C.
  3. Molecular Cancer Therapeutics. 2010, May; 9(5): 1080-1091.
  1. 20.   Global Genomic and Proteomic Analysis Identifies Biological Pathways Related to High-Risk Neuroblastoma
  2. Chen, Q. R.; Song, Y. K.; Yu, L. R.; Wei, J. S.; Chung, J. Y.; Hewitt, S. M.; Veenstra, T. D.; Khan, J.
  3. Journal of Proteome Research. 2010, Jan; 9(1): 373-382.
  1. 21.   Expression Signature Developed from a Complex Series of Mouse Models Accurately Predicts Human Breast Cancer Survival
  2. He, M.; Mangiameli, D. P.; Kachala, S.; Hunter, K.; Gillespie, J.; Bian, X. P.; Shen, H. C. J.; Libutti, S. K.
  3. Clinical Cancer Research. 2010, Jan; 16(1): 249-259.
  1. 22.   Whole chromosome alterations predict survival in high-risk neuroblastoma without MYCN amplification
  2. Bilke, S.; Chen, Q. R.; Wei, J. S.; Khan, J.
  3. Clinical Cancer Research. 2008 14(17): 5540-5547.
  1. 23.   A stromal gene signature associated with inflammatory breast cancer
  2. Boersma, B. J.; Reimers, M.; Yi, M.; Ludwig, J. A.; Luke, B. T.; Stephens, R. M.; Yfantis, H. G.; Lee, D. H.; Weinstein, J. N.; Ambs, S.
  3. International Journal of Cancer. 2008 122(6): 1324-1332.
  1. 24.   An integrated cross-platform prognosis study on neuroblastoma patients
  2. Chen, Q. R.; Song, Y. K.; Wei, J. S.; Bilke, S.; Asgharzadeh, S.; Seeger, R. C.; Khan, J.
  3. Genomics. 2008 92(4): 195-203.
  1. 25.   Expression of hypoxia-inducible factor 1 alpha, hypoxia-inducible factor 2 alpha, and von Hippel-Lindau protein in epitheLiaL ovarian neoplasms and allelic loss of von Hippel-Lindau gene: nuclear expression of hypoxia-inducible factor 1 alpha is an independent prognostic factor in ovarian carcinoma
  2. Osada, R.; Horiuchi, A.; Kikuchi, N.; Yoshida, J.; Hayashi, A.; Ota, M.; Katsuyama, Y.; Melilo, G.; Konishi, I.
  3. Human Pathology. 2007, Sep; 38(9): 1310-1320.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel